Corifact 1250 1250 Unit (Factor Xiii POWDER FOR SOLUTION) 1250 UNIT

CORIFACT 1250 is a powder for solution containing Factor XIII, used for managing bleeding disorders. This intravenous medication supports blood clotting and is manufactured by CSL Behring Canada Inc.

Strength

1250 UNIT

Manufacturer / TM Owner

CSL BEHRING CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CORIFACT 1250 is primarily used to treat bleeding disorders related to Factor XIII deficiency. It works by helping blood to clot properly, which is essential for controlling bleeding episodes. This medication is often prescribed for individuals who have a genetic lack of Factor XIII, a protein crucial for blood coagulation. People may wonder, 'What is Factor XIII used for?' and the answer lies in its role in stabilizing blood clots to prevent excessive bleeding.

Side Effects

When administered intravenously, CORIFACT 1250 helps to stabilize blood clots, reducing the risk of bleeding episodes. Common effects may include improved clotting ability, which can be particularly beneficial for individuals with bleeding disorders. It's important to note that individual responses to the medication can vary, and not everyone will experience the same effects.

Precautions & Warnings

CORIFACT 1250 should be handled with care and stored as directed to maintain its effectiveness. It is crucial to follow the healthcare provider's instructions for administration and to report any unusual symptoms. Individuals with known allergies to any components of the medication should avoid its use. Always consult a healthcare professional before starting any new medication.

Avoid Interactions

CORIFACT 1250 may interact with other medications, so it's important to inform your healthcare provider about all the drugs you are taking. Certain medications, such as blood thinners, may affect the way CORIFACT 1250 works. Additionally, alcohol and other substances may influence the medication's effectiveness, so it's advisable to discuss potential interactions with a healthcare professional.

Frequently Asked Questions

CORIFACT 1250 is used to manage bleeding disorders related to Factor XIII deficiency by aiding in blood clotting.

CORIFACT 1250 is administered intravenously as a powder for solution.

Common effects include improved blood clotting and reduced risk of bleeding episodes.

CORIFACT 1250 is manufactured by CSL Behring Canada Inc.

Follow healthcare provider instructions, report unusual symptoms, and avoid if allergic to any components.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.